Platinum-Based Chemotherapy for Ovarian Cancer

Platino-resistance in Ovarian Cancer

Recruiting N/A Interventional Study
Epithelial Ovarian Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Other
Participants needed
600 (estimated)
Sponsor
Institut Claudius Regaud · Other
Who this trial is looking for

This trial is looking for patients with epithelial ovarian cancer to help understand why some do not respond to platinum-based chemotherapy. Participants will receive standard treatment and have some biological samples collected during their care over 5 years.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years old or older
  • I have been diagnosed with epithelial ovarian cancer
  • I have not started curative treatment except for neo-adjuvant treatment
  • My doctor recommends platinum-based chemotherapy
  • I am affiliated with the French social security system
  • I will provide written consent to participate

You may not be able to join if

  • I have a non-epithelial ovarian tumor or a borderline ovarian tumor
  • I have recurrent ovarian cancer
  • My exploratory surgery was not performed at the Institut Universitaire du Cancer de Toulouse - Oncopole
  • I am pregnant or breastfeeding
  • I have any conditions that may prevent me from following medical advice or study procedures
  • I am under legal protection or have lost my freedom by judicial decision

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Prospective, monocentric study aiming to identify factors involved in platinum based-chemotherapy resistance in patients with epithelial ovarian cancer (all stages). Patients will receive treatment (platinum based-chemotherapy) according to the standard practices. A prospective database and an associated biological collection will be performed during 5 years: * For each patient: clinical, biolo…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years old 2. Epithelial ovarian cancer at initial diagnosis (all stages) 3. Curative treatment (exeresis surgery) not yet initiated excepted neo-adjuvant treatment 4. Indication of platinum based-chemotherapy 5. Patient affiliated to the french social security system…
Contacts

Gwenaël FERRON

05 31 15 53 55

Ferron.Gwenael@iuct-oncopole.fr

CONTACT